True Link Financial Advisors’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-203
Closed -$29.8K – 418
2026
Q1
$29.8K Buy
+203
New +$31.3K ﹤0.01% 259
2023
Q4
– Sell
-2,635
Closed -$339K – 109
2023
Q3
$339K Buy
2,635
+130
+5% +$17.3K 0.04% 86
2023
Q2
$332K Hold
2,505
– – 0.04% 95
2023
Q1
$324K Sell
2,505
-12
-0.5% -$1.57K 0.04% 99
2022
Q4
$342K Buy
2,517
+12
+0.5% +$1.59K 0.05% 90
2022
Q3
$303K Buy
+2,505
New +$323K 0.04% 110
2022
Q1
– Sell
-850
Closed -$174K – 290
2021
Q4
$174K Hold
850
– – 0.02% 269
2021
Q3
$153K Buy
850
+225
+36% +$29.7K 0.02% 284
2021
Q2
$112K Sell
625
-703
-53% -$86.2K 0.02% 286
2021
Q1
$223K Buy
1,328
+261
+24% +$30.1K 0.03% 208
2020
Q4
$172K Buy
+1,067
New +$116K 0.03% 287

Other funds holding XLV

True Link Financial Advisors's XLV Position: Q2 2026 in Review

True Link Financial Advisors sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q2 2026, closing a stake of 203 shares — an estimated $29.8K sold.

True Link Financial Advisors first reported a position in XLV in Q4 2020 and held it in 11 quarters. The position peaked at $342K in Q4 2022. 1,866 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

  • True Link Financial Advisors reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q2 2026 after selling out during the quarter.
  • True Link Financial Advisors sold 203 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $29.8K.
  • True Link Financial Advisors first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2020 and held it in 11 quarters.
  • True Link Financial Advisors's State Street Health Care Select Sector SPDR ETF position peaked at $342K in Q4 2022.
  • 1,866 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on True Link Financial Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.